Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Irene Carrión Barberà"'
Autor:
Lilian López Núñez, Irene Carrión-Barberà, Luis Molina, Isabel Padró, Manel Ciria, Laura Tío, Tarek Carlos Salman-Monte, Ana Pros
Publikováno v:
Medicina Clínica. 160:434-442
Autor:
Irene Carrión-Barberà, Tarek Carlos Salman-Monte, Sonia Castell, Francisco Castro-Domínguez, Fabiola Ojeda, Jordi Monfort
Publikováno v:
European Journal of Rheumatology, Vol 6, Iss 3, Pp 150-152 (2019)
Externí odkaz:
https://doaj.org/article/0abe8bc479d2473bafd9b9c5f4d2040c
Publikováno v:
Lupus Science and Medicine, Vol 6, Iss 1 (2019)
Objectives Lupus nephritis (LN) requires renal replacement therapy in 10%–30% of patients. About 30% of these patients receive a kidney transplant. Belatacept is a second-generation, selective, T-cell co-stimulator blocker (inhibits cytotoxic, T-ly
Externí odkaz:
https://doaj.org/article/41d9edbd58b5455e938c3bcf3c19c6e6
Autor:
Jordi Monfort, Laura Gimeno-Torres, Eduardo Villegas, Xavier Durán, Irene Carrión-Barberà, Tarek Carlos Salman-Monte
Publikováno v:
Lupus. 30:2095-2101
Background Systemic lupus erythematosus (SLE) is an autoimmune multisystemic disease with a wide variety of clinical manifestations. One of its symptoms, associated to high morbidity, is serositis. Its prevalence ranges between 11% and 54%, and littl
Autor:
Irene Altabás-González, Iñigo Rúa-Figueroa, Francisco Rubiño, Coral Mouriño Rodríguez, Iñigo Hernández-Rodríguez, Raul Menor Almagro, Esther Uriarte Isacelaya, Eva Tomero Muriel, Tarek C Salman-Monte, Irene Carrión-Barberà, Maria Galindo, Esther M Rodríguez Almaraz, Norman Jiménez, Luis Inês, José Maria Pego-Reigosa
Objectives To apply the lupus low disease activity state (LLDAS) definition within a large cohort of patients and to assess the agreement between the LLDAS and the physician’s subjective evaluation of lupus activity. Methods We conducted a cross-se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b24b1f6da11fb015c71210b756adee
https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac462/45758979/keac462.pdf
https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac462/45758979/keac462.pdf
Autor:
Juan Antonio Meraz-Ostíz, Francisco Vílchez-Oya, Mònica Gonzàlez-Farré, Irene Carrión-Barberà, Jose Antonio Carrión, Tarek Carlos Salman-Monte
Publikováno v:
Reumatología Clínica (English Edition). 18:309-311
Isolated extrapulmonary involvement in sarcoidosis is uncommon and reported in 5–9% of systemic sarcoidosis, this constitutes a clinical challenge due to its extensive differential diagnosis. Extrapulmonary sarcoidosis affecting more than three org
Le tocilizumab peut induire une hypogammaglobulinémie secondaire. Série rétrospective de 42 patients
Autor:
Ana Pros, Francisco Vílchez-Oya, Carolina Pérez-García, Irene Carrión-Barberà, Juan Antonio Meraz-Ostíz, Tarek Carlos Salman-Monte
Publikováno v:
Revue du Rhumatisme. 88:152-155
Autor:
Irene Carrión Barberà, Anna Agustí Claramunt, Bernat Mas Matas, Albert Solano López, Raúl Torres-Claramunt, Salvatore Marsico
Publikováno v:
Open Journal of Orthopedics. 11:233-248
Increased posterior tibial slope (PTS), medial tibial plateau slope (MTPS) and lateral tibial plateau slope (LTPS) have been proposed as potential risk factors for anterior cruciate ligament (ACL) tear. However, prior literature is inconclusive. The
Autor:
Vicenç Juan Gómez, Vicenç Torrente-Segarra, Asunción Acosta, Jordi Monfort, Tarek Carlos Salman Monte, Irene Carrión-Barberà
Publikováno v:
Reumatología Clínica. 16:391-395
espanolAntecedentes El lupus eritematoso sistemico (LES) es una enfermedad cronica autoinmune que afecta a multiples organos y sistemas. Las celulas B tienen un papel critico en la patogenesis del LES. El rituximab (RTX) es un farmaco compuesto por a
Autor:
Tarek Carlos Salman-Monte, J. M. Sánchez-Schmidt, C. Pérez-García, Jordi Monfort, Francisco Vílchez-Oya, Irene Carrión-Barberà, Ana Pros
Publikováno v:
Clinical Rheumatology. 40:2065-2070
Polyarteritis nodosa is a primary systemic necrotizing vasculitis whose evolution follows, in many cases, a chronic remitting-recurrent course with refractoriness to conventional immunosuppressants. We report here the clinical case of a 75-year-old p